Endoscopic Injection Needle Market was valued at USD 0.85 Billion in 2022 and is projected to reach USD 1.25 Billion by 2030, growing at a CAGR of 5.3% from 2024 to 2030.
The endoscopic injection needle market is currently experiencing substantial growth, driven by advancements in minimally invasive procedures and a growing preference for non surgical treatments. The market size was valued at approximately USD 350 million in 2023, with a projected annual growth rate of 6 8% over the next 5 to 10 years. This growth is driven by factors such as the increasing prevalence of gastrointestinal diseases, advancements in medical technology, and an aging population seeking less invasive treatment options.
Endoscopic injection needles are used in various medical fields, primarily for delivering therapeutic agents through endoscopic procedures. This includes applications such as cancer treatments, gastrointestinal issues, and chronic pain management. Technological innovations, including precision needle tips and ergonomic designs, are enhancing the efficacy of these treatments, contributing to market growth.
Get an In-Depth Research Analysis of the Global Endoscopic Injection Needle Market Size And Forecast [2025-2032]
Several key drivers are fueling the growth of the endoscopic injection needle market:
Technological Advancements: The integration of high precision technologies, such as advanced imaging systems and robotic assisted procedures, allows for more accurate injections, boosting the adoption of endoscopic injections.
Rising Incidence of Gastrointestinal Diseases: Disorders like ulcers, tumors, and gastrointestinal bleeding require endoscopic interventions, thus driving the need for effective injection needles.
Minimally Invasive Procedures: As patients increasingly demand less invasive treatment options, endoscopic injections provide a viable alternative to traditional surgical methods, driving market growth.
Aging Population: An aging global population is more prone to chronic diseases, thereby increasing demand for endoscopic procedures for treatments such as cancer, GERD, and Crohn’s disease.
Despite the promising growth, the market faces certain restraints:
High Cost: Endoscopic injection needles and the procedures associated with them can be expensive, particularly in developing countries, limiting market penetration.
Regulatory Hurdles: The approval process for medical devices can be long and complex, delaying product launches and innovations in the market.
Need for Skilled Professionals: The effectiveness of endoscopic injection procedures is highly dependent on the skill of the healthcare professional, which can limit the adoption of these treatments in some regions.
The endoscopic injection needle market presents several growth opportunities:
Emerging Markets: As healthcare infrastructure improves in regions such as Asia Pacific, there is a growing demand for advanced medical devices, presenting untapped growth opportunities.
Collaborations and Strategic Partnerships: Partnerships between medical device companies and hospitals or healthcare providers can drive market expansion and innovation.
Personalized Medicine: The development of personalized endoscopic treatment options tailored to individual patients is a key growth area for the market.
The endoscopic injection needle market can be segmented based on application into:
Cancer Treatment: Injection needles are frequently used in treating tumors by delivering chemotherapy or other therapeutic agents directly to cancerous tissues.
Gastrointestinal Disorders: Endoscopic injections are often used for conditions such as Crohn's disease, ulcers, and bleeding, helping to alleviate symptoms and provide targeted treatments.
Chronic Pain Management: Chronic pain, particularly in the spine and joints, can be managed with targeted injections via endoscopy, offering effective relief with minimal recovery time.
The endoscopic injection needle market is also segmented by end user, which includes:
Hospitals: Hospitals are the primary end users of endoscopic injection needles due to their advanced healthcare infrastructure and high patient volume.
Specialty Clinics: Clinics focusing on specific treatments such as gastrointestinal, oncology, or pain management are increasing their use of endoscopic procedures.
Ambulatory Surgical Centers ASCs: The rising adoption of outpatient surgical centers for minor endoscopic procedures is also driving demand in this segment.
Geographically, the market is divided into:
North America: The largest market, with the United States leading due to advanced healthcare facilities, high healthcare expenditure, and a strong prevalence of chronic diseases.
Europe: A well established market with a growing demand for minimally invasive procedures and increasing healthcare investments in countries like Germany and the UK.
Asia Pacific: Rapidly emerging as a significant market due to improving healthcare infrastructure, increasing disposable income, and rising incidences of gastrointestinal diseases.
Latin America: A growing healthcare sector, coupled with increased awareness about endoscopic treatments, is expected to drive the market in countries like Brazil and Mexico.
Middle East and Africa: A developing market with growing healthcare investments in the region's major economies like the UAE and Saudi Arabia.
Some of the prominent companies operating in the endoscopic injection needle market include:
Boston Scientific Corporation: A global leader in medical devices, Boston Scientific offers a variety of endoscopic products, including advanced injection needles.
Cook Medical: Specializing in minimally invasive devices, Cook Medical is a key player in the endoscopic injection needle market, offering a range of products used in gastrointestinal and oncology treatments.
Medtronic: Medtronic’s offerings in the gastrointestinal space include endoscopic systems and accessories, including advanced injection needles.
Olympus Corporation: A major player in the endoscopic device industry, Olympus provides high quality injection needles for therapeutic applications.
Conmed Corporation: Known for its minimally invasive surgical tools, Conmed manufactures endoscopic needles and associated equipment for a variety of applications.
Several emerging trends and innovations are shaping the endoscopic injection needle market:
Precision and Automation: The integration of robotic assisted systems and image guided technologies is improving the accuracy and efficiency of endoscopic procedures, leading to better patient outcomes.
Single Use Needles: Single use needles are gaining popularity due to their ability to reduce infection risks and lower healthcare costs.
Minimally Invasive Techniques: There is an increasing focus on reducing recovery time and surgical trauma by using less invasive techniques and smaller, more efficient needles.
Despite its promising growth, the endoscopic injection needle market faces several challenges:
Supply Chain Issues: Global supply chain disruptions, particularly in the wake of the COVID 19 pandemic, have affected the production and distribution of medical devices. Solutions include diversifying supply sources and increasing local production capabilities.
Pricing Pressures: Healthcare providers face budget constraints, which can hinder the widespread adoption of advanced devices. Offering cost effective solutions or bundled pricing can help address this challenge.
Regulatory Barriers: Stringent regulatory requirements and approval processes can slow down innovation. Expedited regulatory pathways and harmonizing regulations across regions could help streamline market entry.
The future of the endoscopic injection needle market looks promising, with consistent growth expected over the next decade. Key drivers such as technological advancements, a growing demand for minimally invasive procedures, and a rising prevalence of gastrointestinal and oncology related conditions will continue to shape the market's evolution. Additionally, expanding healthcare access in emerging markets will provide new growth opportunities for industry players.
North America and Europe are currently the leading regions, driven by advanced healthcare infrastructure and high demand for minimally invasive treatments. However, the Asia Pacific region is rapidly emerging as a significant market.
The primary applications include cancer treatment, gastrointestinal disorders, and chronic pain management. These areas are witnessing increased adoption due to the growing preference for non invasive treatments.
Supply chain disruptions, pricing pressures, and regulatory hurdles are some of the key challenges. Companies are addressing these issues by diversifying suppliers, innovating cost effective solutions, and working towards faster regulatory approvals.
Major players in the market include Boston Scientific Corporation, Cook Medical, Medtronic, Olympus Corporation, and Conmed Corporation, all of which are driving innovation and expanding their product offerings.
The endoscopic injection needle market is expected to grow steadily, driven by advancements in technology, a rising incidence of chronic diseases, and expanding healthcare access in emerging markets.
```This code outlines all the requested sections and content in a structured format suitable for rendering on a web page. Let me know if you need further adjustments!
Cook Medical
Boston Scientific
Steris
Carbon Medical Technologies
GI Supply
Endo-Therapeutics
Ace Medical Devices
Conmed
MTW Endoskopie Manufaktur
Olympus
Upex-med
Changzhou Jiuhong Medical
AteTec
Jiangsu Grit Medical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Endoscopic Injection Needle Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Endoscopic Injection Needle Market
Hospitals
Clinics
Others
Based on Types the Market is categorized into Below types that held the largest Endoscopic Injection Needle market share In 2023.
Diameter 19G
Diameter 22G
Diameter 23G
Diameter 25G
Diameter 26G
Others
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Endoscopic Injection Needle Market Research Analysis
1. Introduction of the Global Endoscopic Injection Needle Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Endoscopic Injection Needle Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Endoscopic Injection Needle Market, By Type
6. Global Endoscopic Injection Needle Market, By Application
7. Global Endoscopic Injection Needle Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Endoscopic Injection Needle Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/